XML 16 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Fair Value $ 14,955,049 [1],[2] $ 16,470,893 [3],[4]
Cash (restricted cash of $20,399 and $47,448, respectively) 237,438 558,703
Foreign cash (cost of $625 and $9,722, respectively) 611 9,839
Interest and dividend receivable 91,333 104,576
Prepaid expenses and other assets 37,161 15,508
Total Assets 15,354,604 17,186,365
Liabilities    
Debt (net of unamortized debt issuance costs of $101,772 and $93,186, respectively) 7,903,533 9,300,076
Distribution payable 152,874 184,877
Management fee payable 57,348 63,145
Incentive fee payable 36,156 38,899
Accrued expenses and other liabilities 164,477 189,517
Total Liabilities 8,322,845 9,789,086
Commitments and contingencies (Note 8)
Net Assets    
Common shares $0.01 par value, 1,000,000,000 shares authorized; 493,142,569 and 499,448,499 shares issued and outstanding, respectively 4,931 4,994
Additional paid-in-capital 7,442,001 7,512,234
Accumulated undistributed (overdistributed) earnings (415,173) (119,949)
Total Net Assets 7,031,759 7,397,279
Total Liabilities and Net Assets $ 15,354,604 $ 17,186,365
Net Asset Value Per Share (in usd per share) $ 14.26 $ 14.81
Affiliated entity    
Assets    
Receivable from a controlled affiliate $ 33,012 $ 26,846
Liabilities    
Payables to affiliates 8,457 12,572
Non-controlled, non-affiliated investments    
Assets    
Fair Value 12,439,882 13,995,055
Non-controlled, affiliated investments    
Assets    
Fair Value 142,746 114,192
Controlled, affiliated investments    
Assets    
Fair Value $ 2,372,421 $ 2,361,646
[1] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[2] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”
[3] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[4] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”